Does IXEKIZUMAB Cause Product dose omission issue? 832 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 832 reports of Product dose omission issue have been filed in association with IXEKIZUMAB (TALTZ). This represents 2.5% of all adverse event reports for IXEKIZUMAB.
832
Reports of Product dose omission issue with IXEKIZUMAB
2.5%
of all IXEKIZUMAB reports
1
Deaths
15
Hospitalizations
How Dangerous Is Product dose omission issue From IXEKIZUMAB?
Of the 832 reports, 1 (0.1%) resulted in death, 15 (1.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 832 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Therapy interrupted (796)
Injection site pruritus (772)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which IXEKIZUMAB Alternatives Have Lower Product dose omission issue Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID